KLK3 and benign prostatic hyperplasia: In particular, the percentage of α2,3-sialic acid of PSA was increased in the high-risk PCa patients compared with low or intermediate-risk PCa and BPH patients and gave an AUC of 0.971, with 85.7% sensitivity and 95.3% specificity.